Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lusque

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Contemporary Clinical Trials|April 3, 2018
Alternative methodological approach to randomized trial for surgical procedures routinely usedT Filleron, A Lusque, F Dalenc, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 13, 2015
Prenasal thickness to nasal bone length ratio: effectiveness as a second or third trimester marker for Down syndromeA Tournemire, M Groussolles, V Ehlinger, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 12, 2020
Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patientsA Modesto, C Dalmasso, A Lusque, et al.
Radiation Oncology (London, England)|April 21, 2017
Subventricular zones: new key targets for glioblastoma treatmentJ Khalifa, F Tensaouti, A Lusque, et al.
The British Journal of Surgery|April 1, 2021
Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trialG Houvenaeghel, M Cohen, M A Dammacco, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2020
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancerA Martinez, M Voglimacci, A Lusque, et al.
ESMO Open|August 14, 2025
Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvementI Korakis, K Ouali, B Hanvic, et al.
ESMO Open|May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohortN Epaillard, A Lusque, W Jacot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancerF Mosele, B Stefanovska, A Lusque, et al.
British Journal of Cancer|April 3, 2023
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutationJ-S Frenel, A Lusque, S Delaloge, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Contemporary Clinical Trials|April 3, 2018
Alternative methodological approach to randomized trial for surgical procedures routinely usedT Filleron, A Lusque, F Dalenc, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|June 13, 2015
Prenasal thickness to nasal bone length ratio: effectiveness as a second or third trimester marker for Down syndromeA Tournemire, M Groussolles, V Ehlinger, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 12, 2020
Tolerance and efficacy of dose escalation using IMRT combined with chemotherapy for unresectable esophageal carcinoma: Long-term results of 51 patientsA Modesto, C Dalmasso, A Lusque, et al.
Radiation Oncology (London, England)|April 21, 2017
Subventricular zones: new key targets for glioblastoma treatmentJ Khalifa, F Tensaouti, A Lusque, et al.
The British Journal of Surgery|April 1, 2021
Prophylactic nipple-sparing mastectomy with immediate breast reconstruction: results of a French prospective trialG Houvenaeghel, M Cohen, M A Dammacco, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 10, 2020
Tumour and pelvic lymph node metabolic activity on FDG-PET/CT to stratify patients for para-aortic surgical staging in locally advanced cervical cancerA Martinez, M Voglimacci, A Lusque, et al.
ESMO Open|August 14, 2025
Addressing screening failures in early-phase clinical trials in oncology: impact on patient outcomes and strategies for improvementI Korakis, K Ouali, B Hanvic, et al.
ESMO Open|May 4, 2024
Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohortN Epaillard, A Lusque, W Jacot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancerF Mosele, B Stefanovska, A Lusque, et al.
British Journal of Cancer|April 3, 2023
Efficacy of front-line treatment for hormone receptor-positive HER2-negative metastatic breast cancer with germline BRCA1/2 mutationJ-S Frenel, A Lusque, S Delaloge, et al.
Pageof 2